Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
hemosiderosis
MeSH D006486 - hemosiderosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D019190:
Iron overload
25 Companies
2 Drugs
$
Success rate
D006486:
Hemosiderosis
17 Companies
1 Drug
$
Success rate
D000097545:
Pulmonary hemosiderosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
100
%
3/3
Phase 3
100
%
3/3
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cyclophosphamide
Baxter
Cyclophosphamide
Jiangsu Hengrui Medicine
Cyclophosphamide
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use